Fierce Biotech

Fierce Biotech is a news outlet that covers the biopharmaceutical industry with a focus on drug development, regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals and beyond. The site provides daily news analysis and data on drugs and the companies that make them. They also produce special reports on the industry's products and finances as well as trends in the industry.

80%

The Daily's Verdict

This news site has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on its reporting.

Bias

90%

Examples:

  • Fierce Biotech appears to provide balanced coverage of the biopharma industry without any significant examples of editorializing or favoring one party over another.

Conflicts of Interest

100%

Examples:

  • No conflicts of interest were identified.

Contradictions

85%

Examples:

  • In one article, there is a contradictory statement about surgeons viewing patients' anatomy from their living rooms for fun. The same statement also appears in the deceptions summary.

Deceptions

45%

Examples:

  • A deceptive practice found in one article involves a statement suggesting that surgeons can view patients' anatomy from their living rooms for fun. This is misleading and not reflective of the actual use case, which is for medical education and surgical planning.

Recent Articles

  • US Government Awards $176 Million to Moderna for Developing New Bird Flu Vaccine

    US Government Awards $176 Million to Moderna for Developing New Bird Flu Vaccine

    Broke On: Tuesday, 02 July 2024 The US government awards Moderna $176 million to develop and test a new mRNA-based vaccine for the H5N1 avian influenza strain, following recent human cases and concerns over potential transmission. The collaboration with BARDA builds on their success in producing the COVID-19 vaccine. Testing of candidate vaccine mRNA-1018 is underway, with results expected later this year.
  • New Male Birth Control Gel Shows Promise in Clinical Trials: Effectively Reduces Sperm Production in 8 Weeks

    New Male Birth Control Gel Shows Promise in Clinical Trials: Effectively Reduces Sperm Production in 8 Weeks

    Broke On: Wednesday, 05 June 2024 A new hormonal gel for male birth control, which men apply on their shoulders, effectively reduces sperm production within eight weeks according to clinical trials. The rapid suppression of sperm makes it a significant advancement in male contraceptive options and an essential step towards gender equality.
  • Medtronic's Game-Changing Inceptiv: The World's First Closed-Loop Spinal Cord Stimulator for Personalized Chronic Pain Relief

    Medtronic's Game-Changing Inceptiv: The World's First Closed-Loop Spinal Cord Stimulator for Personalized Chronic Pain Relief

    Broke On: Friday, 26 April 2024 Medtronic's new Inceptiv closed-loop spinal cord stimulator, the world's smallest and thinnest fully implantable system, offers personalized chronic pain relief through real-time adjustments based on biological signals. The device features a rechargeable lithium battery and MRI access with no restrictions.
  • Apple's Vision Pro: Revolutionizing Healthcare with 3D Anatomy Scans as Interactive Holograms

    Apple's Vision Pro: Revolutionizing Healthcare with 3D Anatomy Scans as Interactive Holograms

    Broke On: Wednesday, 13 March 2024 Apple's Vision Pro is a new tool that lets doctors view 3D anatomy scans as holograms. It can be used for surgery, medical training and behavioral health. The device costs $3,500 and has various applications in different fields.